X0306 4 2021-12-02 0 0001832415 Better Therapeutics, Inc. BTTX 0001547557 Appelbaum Kevin J C/O BETTER THERAPEUTICS, INC. 548 MARKET STREET, #49404 SAN FRANCISCO CA 94104 1 1 1 0 Chief Executive Officer 0001890904 Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended C/O BETTER THERAPEUTICS, INC. 548 MARKET STREET, #49404 SAN FRANCISCO CA 94104 0 0 1 0 Common Stock 2021-12-02 4 P 0 500 6.84 A 500 D Common Stock 2021-12-03 4 P 0 500 6.426 A 1000 D Common Stock 2406719 I By Trust The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.440 to $6.405, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are owned directly by Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated May 16, 2020, as amended (the "Trust"), and indirectly by Mr. Appelbaum as trustee of the Trust. Mr. Appelbaum is an officer, director and ten percent owner of the Issuer. /s/ Mark Heinen, Attorney-in-Fact for Kevin J. Appelbaum 2021-12-06 /s/ Mark Heinen, Attorney-in-Fact for Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated May 16, 2020, as amended 2021-12-06